Sara Bolin
6PUBLICATIONS
45CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 11, 2022
Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma.Anna Borgenvik, Karl O Holmberg, Sara Bolin
|Nov 23, 2019
BET and Aurora Kinase A inhibitors synergize against MYCN-positive human glioblastoma cells.Matko Čančer, Lisa F Drews, Johan Bengtsson
|Oct 30, 2019
Correction: Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.Ryan T Nitta, Sara Bolin, Emily Luo
|Oct 02, 2019
Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion.Laura M Prolo, Amy Li, Scott F Owen
|Aug 14, 2019
Casein kinase 2 inhibition sensitizes medulloblastoma to temozolomide.Ryan T Nitta, Sara Bolin, Emily Luo
|Sep 13, 2018
Developmental phosphoproteomics identifies the kinase CK2 as a driver of Hedgehog signaling and a therapeutic target in medulloblastoma.Teresa Purzner, James Purzner, Taylor Buckstaff
Pageof 1
Frequent Collaborators
2 joint publications
Michael D Taylor
2 joint publications
Robert J Wechsler-Reya
2 joint publications
Fredrik J Swartling
2 joint publications
Matko Čančer
1 joint publications
Teresa Purzner
1 joint publications
Giorgio Cozza
1 joint publications
Ulrike Litzenburger
1 joint publications
Johanna Theruvath
1 joint publications
Xiao-Nan Li
1 joint publications
Margaret T Fuller
